NIFTY
-1.10  -0.01%
 9871.50
S&P BSE SENSEX
-26.87  -0.08%
 31599.76
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 26-Sep-2017
NSE
8.5    1.21%
Rs. 709.35
 
Days Low
Rs. 697
Days High
Rs. 713.9

Open Rs. 704
 
52 week Low
Rs. 504
52 week High
Rs.895
 
 
Bid :                 0.00 (0)
Offer :        705.00 (50)
BSE
Rs.708.50
5.95    0.85%
on 26-Sep-2017
BSE
5.95    0.85%
Rs. 708.50
 
Days Low
Rs. 696
Days High
Rs. 714.6

Open Rs. 701
 
52 week Low
Rs. 503.05
52 week High
Rs.895
 
 
Bid :                 0.00 (0)
Offer :        705.00 (50)
NSE
Rs.709.35
8.5    1.21%
 
 
Last Price (Rs.)  708.50 Value  1024717060.00
Net Change (Rs.)  5.95 Best Buy  0.00
Volume  1454769 Best Sell  705.00
Prev.Close (Rs.)  702.55 Best Quantity  0
Open (Rs.)  704.00 Sell Quantity  50
High (Rs.)  713.90 52-Week High (Rs.)  895.00
Low (Rs.)  697.00 52-Week Low (Rs.)  504.00
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  415097.69
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Currents Investments0.20 0.20 196.40 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 507.45 1217528 81.60 0.00 0.69
Cadila Healthcare 474.30 485561 65.54 73.38 0.67
Cipla 578.15 465229 161.56 47.71 0.35
Piramal Enterprises 2683.15 463013 838.20 59.60 0.78
Lupin 1005.15 454124 331.14 14.45 0.75
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Jun 2017Mar 2017Dec 2016
Net Sales21882.9024200.9025213.70
Operating Profit5002.606312.106634.80
PBDT4900.106221.506532.80
Net Profit3073.304554.604410.20
More> 
 
Company News
9/26/2017 12:00:00 AM
Aurobindo Pharma trades higher on the bourses
9/25/2017 12:00:00 AM
Updates
9/1/2017 12:00:00 AM
Updates
More>
 
Ratios
   Earnings Per Share (Rs)29.13 
   Book NAV/Share(Rs)143.99 
   PAT Margin (%)17.45 
   Asset Turnover(x)0.76 
   PER(x)23.18 
   Yield(%)0.37 
   EV/Core EBITDA(x)16.96 
   M Cap / Sales4.12 
   Net Sales Growth(%)4.81 
   PAT Growth(%)4.92 
   Total Debt/Equity(x)0.36 
   Current Ratio(x)1.55 
   Quick Ratio(x)1.00 
   Total Debt/Mcap(x)0.08 
More>